Latest News about Jazz
Recent news which mentions Jazz
From MarketWatch
From Benzinga
10 Biggest Price Target Changes For Monday
December 20, 2021
From Benzinga
The Week In Cannabis: Pfizer, Visa, $730M+ In Financings, Malta, EU, Columbia Care, MedMen, Uruguay And More
December 17, 2021
From Benzinga
10 Biggest Price Target Changes For Friday
December 17, 2021
From Benzinga
7 Meme Stocks to Buy on Their Market Slump and Rebound
December 14, 2021
From InvestorPlace
Are Cannabinoids the Next Frontier of Pharmaceuticals? This Company Thinks So and Wants to Lead the Pack
December 14, 2021
From Benzinga
A Tribe for Jazz presents an evening of jazz honoring Columbus’s premier children’s music educator Becky Ogden with a performance by The Jon Irabagon Quartet
December 14, 2021
Tickers
JAZZ
From PRUnderground
How Pfizer Is Getting Into Cannabis With $6.7B Arena Pharma Deal
December 13, 2021
From Benzinga
Jazz Posts New Data for ALL/LBL Treatment At ASH 2021 Annual Meeting
December 13, 2021
Tickers
JAZZ
From Benzinga
Jupiter Wellness Just Reported A Big Move In Pharma
December 10, 2021
From Benzinga
3 High-Growth Stocks That Are Screaming Buys in December
December 09, 2021
From Motley Fool
Got $5,000? Buy These 3 Hot Pot Stocks Immediately
November 27, 2021
From Motley Fool
EXCLUSIVE: Cannabis-Based Drug Approved For Cancer Treatment In Peru
November 22, 2021
Tickers
JAZZ
From Benzinga
2 Top Marijuana Stocks to Buy for the Long Haul
November 21, 2021
From Motley Fool
Better Buy: Compass Pathways vs. Jazz Pharmaceuticals
November 21, 2021
From Motley Fool
Is Now the Right Time to Buy Compass Pathways?
November 13, 2021
From Motley Fool
The Week In Cannabis: Earnings Season, A GOP Legalization Bill, Seth Rogen & Sarah Silverman's Campaign
November 12, 2021
From Benzinga
Is Compass Pathways Stock a Once-in-a-Lifetime Bargain?
November 11, 2021
From Motley Fool
7 F-Rated Stocks to Sell Before We Reach Christmas
November 10, 2021
From InvestorPlace
Jazz Pharmaceuticals PLC (JAZZ) Q3 2021 Earnings Call Transcript
November 10, 2021
Tickers
JAZZ
From Motley Fool
Jazz Pharmaceuticals Reports Q3 Financial Results, Raises Full-Year Earnings Guidance
November 09, 2021
Tickers
JAZZ
From Benzinga
The Daily Biotech Pulse: Double Dose Of Positive Tidings For Merck, Alkermes Slips On Partial Termination Of J&J Licensing Deal, Amgen Migraine Drug Data
November 09, 2021
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.